[HTML][HTML] Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: new challenges and therapeutic opportunities
ML De Angelis, F Francescangeli, A Zeuner - Cancers, 2019 - mdpi.com
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …
to prevent or treat metastatic disease are still inadequate although great progress has been …
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
ML De Angelis, F Francescangeli, A Zeuner - Cancers, 2019 - pubmed.ncbi.nlm.nih.gov
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …
to prevent or treat metastatic disease are still inadequate although great progress has been …
[HTML][HTML] Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
ML De Angelis, F Francescangeli, A Zeuner - Cancers, 2019 - ncbi.nlm.nih.gov
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …
to prevent or treat metastatic disease are still inadequate although great progress has been …
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
M De Angelis, F Francescangeli, A Zeuner - Cancers, 2019 - cir.nii.ac.jp
抄録< jats: p> Breast cancer is the most frequent cancer among women worldwide.
Therapeutic strategies to prevent or treat metastatic disease are still inadequate although …
Therapeutic strategies to prevent or treat metastatic disease are still inadequate although …
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
ML De Angelis, F Francescangeli, A Zeuner - Cancers, 2019 - europepmc.org
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …
to prevent or treat metastatic disease are still inadequate although great progress has been …
[PDF][PDF] Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
ML De Angelis, F Francescangeli, A Zeuner - pdfs.semanticscholar.org
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …
to prevent or treat metastatic disease are still inadequate although great progress has been …
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
ML De Angelis, F Francescangeli - Cancers, 2019 - search.proquest.com
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …
to prevent or treat metastatic disease are still inadequate although great progress has been …
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
ML De Angelis, F Francescangeli, A Zeuner - Cancers, 2019 - europepmc.org
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …
to prevent or treat metastatic disease are still inadequate although great progress has been …